Clinical Trial Alert

Nephrology Times:
doi: 10.1097/01.NEP.0000413149.59388.14
Clinical Trial Alert

    The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

    Back to Top | Article Outline

    • Anemia •

    NCT01519947

    A Study of the Effect of Altitude

    on Mircera (Methoxy Polyethylene

    Glycol-Epoetin Beta) Dose

    Requirements in Patients with

    Chronic Renal Anemia in

    Predialysis or Dialysis

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators:

    Hoffman-La Roche

    Contact: Genentech

    Phone: 888-662-6728 (Reference study

    ID ML25754)

    E-mail: genentechclinicaltrials@druginfo.com

    Back to Top | Article Outline

    • Cardiovascular Disease •

    NCT01515878

    Hemocontrol's Effectiveness on

    the Reduction of Cardiovascular

    Long-Term Events (HERACLES)

    Ages eligible for study: 65 years

    and older

    Sponsors and collaborators: Azienda

    Ospedaliera Universitaria di Bologna

    Policlinico S. Orsola Malpighi

    Contact: Prof. Antonio Santoro

    Phone: +39 051 6362 430

    E-mail: antonio.santoro@aosp.bo.it

    Back to Top | Article Outline

    • Chronic Kidney Disease •

    NCT01517841

    Barriers to Peritoneal Dialysis

    Selection

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators:

    Suma Prakash

    Contact: Anna McGrail

    E-mail: amcgrail@metrohealth.org

    Back to Top | Article Outline

    • Chronic Kidney Disease-Mineral and Bone Disorder •

    NCT01521494

    PA21 Phase II Clinical Study in

    Hemodialysis Patients with

    Hyperphosphatemia

    Ages eligible for study: 20 years and

    older

    Sponsors and collaborators: Kissei

    Pharmaceutical Co.

    Contact: Kissei Pharmaceutical Co.

    E-mail: rinsyousiken@pharm.kissei.co.jp

    Back to Top | Article Outline

    • Diabetes •

    NCT01512849

    A Study to Evaluate the PK/PD

    and Safety of TA-7284 in Patients

    with Type 2 Diabetes Mellitus Who

    Have Moderate Renal Impairment

    Ages eligible for study: 40 years

    to 79 years

    Sponsors and collaborators: Mitsubishi

    Tanabe Pharma

    Contact: Clinical Trials Information

    Desk

    E-mail: cti-inq-ml@ml.mt-pharma.co.jp

    NCT01524705

    Fluctuation Reduction with

    Insulin and Glp-1 Added Together

    (FLAT-SUGAR)

    Ages eligible for study: 40 years

    to 75 years

    Sponsors and collaborators: University

    of Washington, Eli Lilly and Company,

    Novo Nordisk, Sanofi-Aventis,

    Amylin Pharmaceuticals, Dexcom,

    Bayer, Medicomp, University of

    Texas, Department of Veterans Affairs,

    Biomedical Research Institute of New

    Mexico

    Contact: Jeffrey L. Probstfield, MD

    Phone: 206-616-0292

    E-mail: jeffprob@u.washington.edu

    Contact: Irl B. Hirsch, MD

    Phone: 206-598-4980

    E-mail: ihirsch@u.washington.edu

    NCT01513746

    Eating Disorders in Type 1 Diabetes:

    Mechanisms of Comorbidity

    Ages eligible for study: 18 years

    to 65 years

    Sponsors and collaborators: Duke

    University, National Institute of

    Diabetes and Digestive and Kidney

    Diseases

    Contact: Rhonda M. Merwin, PhD

    Phone: 919-681-7231

    E-mail: rhonda.merwin@duke.edu

    Back to Top | Article Outline

    • Hemodialysis •

    NCT01520207

    Mannitol: Potential Role in

    Hemodialysis Initiation for

    Reduction of Intradialytic

    Hypotension

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators: Brigham

    and Women's Hospital

    Contact: Sushrut S. Waikar, MD,

    MPH

    Phone: 617-732-8473

    E-mail: swaikar@partners.org

    Contact: Finnian R. McCausland,

    MBBCh

    Phone: 617-264-3057

    E-mail: fmccausland@partners.org

    Back to Top | Article Outline

    • Hypertension •

    NCT01522430

    Study of Catheter-Based Renal

    Denervation Therapy in

    Hypertension (DEPART)

    Ages eligible for study: 18 years

    to 85 years

    Sponsors and collaborators: Erasme

    University Hospital

    Contact: Jean-François Argacha, MD

    Phone: 33225555214

    E-mail: jean.francois.argacha@erasme.ulb.ac.be

    NCT01520506

    Rapid Renal Sympathetic

    Denervation for Resistant

    Hypertension (RAPID)

    Ages eligible for study: 18 years

    to 85 years

    Sponsors and collaborators: Maya

    Medical, Meditrial Europe

    Contact: Monica Tocchi, MD, PhD

    Phone: 00393931155344

    E-mail: medical@meditrialeurope.com

    Back to Top | Article Outline

    • Kidney Stones •

    NCT01526304

    The Role of FGF23, Klotho,

    and Sclerostin in Kidney Stone

    Formers

    Ages eligible for study: 18 years

    to 70 years

    Sponsors and collaborators: University

    of Zurich

    Contact: Marian Struker

    Phone: +41 (0)44 255 35 45

    E-mail: marian.struker@usz.ch

    Contact: Nilufar Mohebbi, MD

    E-mail: nilufar.mohebbi@usz.ch

    NCT01514032

    Extracorporeal Shock Wave

    Lithotripsy Versus Retrograde

    Intrarenal Surgery for the

    Treatment of Kidney Stones

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators: University

    of Zurich

    Contact: Damian Weber, MD

    Phone: +41 44 2555407

    E-mail: damian.weber@usz.ch

    Contact: Michael Muentener, MD

    Phone: +41 44 2555403

    E-mail: michael.muentener@usz.ch

    Back to Top | Article Outline

    • Pharmacokinetics •

    NCT01510899

    A Study on the Effect of Renal

    Impairment on the Pharmacokinetics

    of RO4917838

    Ages eligible for study: 18 years

    to 70 years

    Sponsors and collaborators:

    Hoffmann-La Roche

    Contact: Genentech

    Phone: 888-662-6728 (Reference study

    ID BP25261)

    E-mail: genentechclinicaltrials@druginfo.com

    NCT01512667

    Pharmacokinetic Assessment of

    Single-Dose Odanacatib

    (MK-0822) in Subjects with Severe

    Renal Insufficiency (MK-0822-067)

    Ages eligible for study: 18 years

    to 79 years

    Sponsors and collaborators: Merck

    Contact: Merck

    Phone: 888-577-8839

    Back to Top | Article Outline

    • Transplantation •

    NCT01515605

    Molecular Biological and

    Molecular-Genetic Monitoring

    of Therapy After Kidney

    Transplantation

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators:

    Odense University Hospital

    Contact: Dr. Martin Tepel

    Phone: 4565503755

    E-mail: mtepel@health.sdu.dk

    NCT01517984

    Immune Monitoring and CNI

    Withdrawal in Low-Risk

    Recipients of Kidney

    Transplantation

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators: National

    Institute of Allergy and Infectious

    Diseases

    Contact: Brandy Haydel

    Phone: 212-241-0255

    E-mail: Brandy.Haydel@mountsinai.org

    NCT01524601

    The Rosuvastatin in Transplant

    Recipients Study (RITA)

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators:

    University of Oslo School of Pharmacy

    Contact: Karsten Misdtevdt, MD, PhD

    Phone: +472307000, ext. 1894

    E-mail: karsten.midtevdt@rikshospitalet.no

    NCT01513707

    The Effects of Pretransplant

    Dialysis Modality on Posttransplant

    Events

    Ages eligible for study: 20 years

    to 70 years

    Sponsors and collaborators:

    Hayoung Oh, Baxter

    Contact: Hayoung Oh

    Phone: 82-2-3410-3440

    E-mail: hayoung.oh@samsung.com

    Contact: Eunkyoung Jung

    Phone: 82-70-7014-4164

    E-mail: gait77.jung@samsung.com

    NCT01525329

    Combination Therapy with

    5-Fluorouracil and Photodynamic

    Therapy for the Treatment of

    Posttransplant Premalignant Skin

    Disease

    Ages eligible for study: 18 years

    and older

    Sponsors and collaborators:

    The Cleveland Clinic,

    National Cancer Institute

    Contact: Margo Riha, BSN, RN

    Phone: 216-445-8616

    E-mail: riham@ccf.org

    Contact: Sara Lohser, MD

    Phone: 216-444-3347

    E-mail: lohsers@ccf.org

    © 2012 Lippincott Williams & Wilkins, Inc.